About IrriMax
IrriMax is a Healthcare company based in Lawrenceville (United States) founded in 2003, and was acquired by ARCHIMED in August 2024. Wound irrigation systems are developed to prevent surgical infections. The company has 51 employees. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its legal entity is Irrimax Corporation. Its competitors include Aplion Medical and Twin Star Medical; 2 of its 2 listed competitors have raised funding.
Company details
IrriMax was founded in 2003 as a subsidiary of Innovation Technologies and is based in Lawrenceville, United States. Operations focus on the medical device sector, where wound irrigation solutions are developed to treat and prevent infections in surgical procedures. Key products include the FDA-cleared IrriSept system, which uses 0.05 chlorhexidine gluconate for debridement and pathogen reduction, along with IrriRinse, SplatterGuard, IrriProbe, and SplatterMatters, all registered trademarks of the parent company.
- Headquarters Lawrenceville, United States
- Employees 51
- Stage Acquired
- SectorsHealthcare
- Website irrimax.com
- Social LinkedIn X
- Acquired by ARCHIMED (Aug 2024)
- Legal Name Irrimax Corporation
- InvestorsDecathlon Capital Partners
& 1 more
- Employee Count51
- Acquired byARCHIMED
(Aug 2024)
Funding Insights of IrriMax
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of IrriMax with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in IrriMax
IrriMax has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Decathlon Capital Partners and ARCHIMED.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt funds focused on direct lending, and revenue-based financing | 2010 | decathloncapital.com | Palo Alto, United States | |
Healthcare industries are funded and supported globally by ARCHIMED. | archimed.group | Lyon, France |
Investor details for IrriMax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IrriMax
3 dated milestones of IrriMax across 21 years, from founding to its latest funding, stage changes and deals.
- Founded IrriMax is founded.
- Funding First funding round.
- Exit Acquired by ARCHIMED.
Competitors of IrriMax
IrriMax has 2 listed competitors in our database, 2 of them funded. They include Aplion Medical and Twin Star Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aplionmedical.com | 2009 | Salt Lake, United States | $1.83M | Chronic wounds are treated with specialized medical devices. | ||
| twinstarmedical.com | 1997 | Minneapolis, United States | $95,000 | Develops innovative porous catheter systems with vacuum and infusion technologies. |
Detailed competitors of IrriMax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
3 companies that operate in the same segment as IrriMax (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IrriMax
IrriMax was founded in 2003 and raised its 1st funding round 15 years after it was founded.
IrriMax is headquartered in Lawrenceville, United States.
IrriMax has 51 employees.
IrriMax was founded in 2003 as a subsidiary of Innovation Technologies and is based in Lawrenceville, United States. Operations focus on the medical device sector, where wound irrigation solutions are developed to treat and prevent infections in surgical procedures. Key products include the FDA-cleared IrriSept system, which uses 0.05 chlorhexidine gluconate for debridement and pathogen reduction, along with IrriRinse, SplatterGuard, IrriProbe, and SplatterMatters, all registered trademarks of the parent company.
IrriMax's top competitors include Aplion Medical and Twin Star Medical.
IrriMax has 2 investors. Key investors include Decathlon Capital Partners, and ARCHIMED.
IrriMax operates through Irrimax Corporation.
Yes. IrriMax was acquired by ARCHIMED in August 2024.